Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025
On Monday, Cathie Wood-led Ark Invest made significant trades in five major companies: Palantir Technologies Inc. (NASDAQ:PLTR), Tempus AI Inc. (NASDAQ:TEM), CareDx Inc. (NASDAQ:CDNA), Veracyte Inc. (NASDAQ:VCYT), Adaptive Biotechnologies Corp. (NASDAQ:ADPT).
在週一,由Cathie Wood領導的ARK投資在五家主要公司中進行了重大交易:Palantir Technologies Inc. (納斯達克:PLTR)、Tempus AI Inc. (納斯達克:TEM)、CareDx Inc. (納斯達克:CDNA)、Veracyte Inc. (納斯達克:VCYT)、Adaptive Biotechnologies CORP. (納斯達克:ADPT)。
The PLTR Trade
PLTR交易
Ark Invest's Ark Innovation ETF (NYSE:ARKK) fund sold 140,518 shares of Palantir. This move is significant, considering Ark Invest's recent trend of offloading Palantir shares.
ARK投資的ARK Innovation ETF (紐交所:ARKK) 基金出售了140,518股Palantir。這一舉動意義重大,因爲ARK投資最近有減持Palantir股票的趨勢。
The total value of this trade, based on the latest closing price of $64.98, is approximately $9.1 million.
根據最新的收盤價$64.98,這筆交易的總價值約爲910萬。
This sale follows Ark's disposal of shares worth roughly $15 million the previous week.
這筆交易是繼上週ARK處置了價值約1500萬的股票後進行的。
Palantir stock price has fallen more than 14% over the past month. In just the first two weeks of 2025, the stock has declined nearly 15%.
Palantir的股價在過去一個月中下跌了超過14%。在2025年的前兩週,股價幾乎下降了15%。
The TEM Trade
TEm交易
Ark Invest's ARK Genomic Revolution ETF (BATS:ARKG) and ARKK funds made substantial purchases of Tempus AI Inc. shares. The ARKG fund bought 98,691 shares, while the ARKK fund purchased a whopping 280,192 shares.
ARK投資的ARK生物基因科技革新主動型ETF (BATS:ARKG) 和ARKk基金大規模購買Tempus AI Inc.的股票。ARKG基金購買了98,691股,而ARKk基金則購買了高達280,192股。
Given the latest closing price of $32.34, the total value of these trades amounts to approximately $12.2 million.
根據最新的收盤價32.34美元,這些交易的總價值約爲1220萬。
This move comes amid TEM's 13.81% drop on Monday.
此次交易發生在TEM週一下跌13.81%之際。
Other Key Trades:
其他關鍵交易:
Company | ETF | Transaction | No. Of Shares | Closing price | Approx. Value |
Veracyte Inc. (NASDAQ:VCYT) | ARK Genomic Revolution | Sale | 37,358 | $42.78 | $1.6 million |
Adaptive Biotechnologies Corp. (NASDAQ:ADPT) | ARK Genomic Revolution | Sale | 76,522 | $6.46 | $494,332 |
CareDx Inc. (NASDAQ:CDNA) | ARK Genomic Revolution | Sale | 65,550 | $25.07 | $1.6 million |
公司 | 可交易ETF | Transaction | 股份數量 | 收盤價 | 大約價值 |
Veracyte公司(納斯達克:VCYT) | ARK生物基因科技革新 | 銷售 | 37,358 | $42.78 | $160萬 |
Adaptive Biotechnologies CORP(納斯達克:ADPT) | ARK生物基因科技革新 | 銷售 | 76,522 | $6.46 | $494,332 |
CareDx Inc. (納斯達克:CDNA) | ARK生物基因科技革新 | 銷售 | 65,550 | $25.07 | $160萬 |
Closing price as of Jan. 13, 2025
截至2025年1月13日的收盤價
- Mark Zuckerberg Critiques 'Culturally Neutered' Companies, Advocates For 'Masculine Energy' As Meta Cuts DEI Programs Post-Joe Rogan Appearance
- 馬克·扎克伯格批評 "文化中立 "的公司,倡導 "男性能源 ",同時Meta在喬·羅根出現在後削減DEI項目。
Image via Benzinga YouTube and Unsplash
圖片來源:Benzinga YouTube和Unsplash
This story was generated using Benzinga Neuro and edited by Rounak Jain
這個故事是使用Benzinga Neuro生成並由 Rounak Jain
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因